Using Discrete Choice Experiments to Inform the Benefit-Risk Assessment of Medicines: Are We Ready Yet?
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-2027
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Using Discrete Choice Experiments to Inform the Benefit-Risk Assessment of Medicines: Are We Ready Yet? ; day:23 ; month:5 ; year:2017 ; pages:1-8
PharmacoEconomics ; (23.5.2017), 1-8
- Schlagwort
-
Gesundheitsförderung
Gesundheit
- Urheber
-
Vass, Caroline M.
- Beteiligte Personen und Organisationen
-
Payne, Katherine
SpringerLink (Online service)
- DOI
-
10.1007/s40273-017-0518-0
- URN
-
urn:nbn:de:1111-201706014418
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Vass, Caroline M.
- Payne, Katherine
- SpringerLink (Online service)
Ähnliche Objekte (12)
Can we deploy yet?: How to make your code production ready
Initial data analysis: A new technology not yet ready to use
Pandemic influenza preparedness in the WHO African region: are we ready yet?
AI aiding perioperative anaesthetic management: on the way but not ready yet
Essays on Women's Entrepreneurship : Marginalized by society and yet ready to challenge its norms
Prices and Clinical Benefit of National Price-Negotiated Anticancer Medicines in China
We are not ready yet: limitations of state-of-the-art disease named entity recognizers
Yet
The management of multi-morbidity in elderly patients: Ready yet for precision medicine in intensive care?
Diabetes precision medicine: plenty of potential, pitfalls and perils but not yet ready for prime time
Quantifying benefit-risk preferences for new medicines in rare disease patients and caregivers
Economic cost-benefit analysis of person-centred medicines reviews by general practice pharmacists
Can we deploy yet?: How to make your code production ready
Initial data analysis: A new technology not yet ready to use
Pandemic influenza preparedness in the WHO African region: are we ready yet?
AI aiding perioperative anaesthetic management: on the way but not ready yet
Essays on Women's Entrepreneurship : Marginalized by society and yet ready to challenge its norms
Prices and Clinical Benefit of National Price-Negotiated Anticancer Medicines in China
We are not ready yet: limitations of state-of-the-art disease named entity recognizers
Yet
The management of multi-morbidity in elderly patients: Ready yet for precision medicine in intensive care?
Diabetes precision medicine: plenty of potential, pitfalls and perils but not yet ready for prime time
Quantifying benefit-risk preferences for new medicines in rare disease patients and caregivers
Economic cost-benefit analysis of person-centred medicines reviews by general practice pharmacists
Can we deploy yet?: How to make your code production ready
Initial data analysis: A new technology not yet ready to use
Pandemic influenza preparedness in the WHO African region: are we ready yet?
AI aiding perioperative anaesthetic management: on the way but not ready yet
Essays on Women's Entrepreneurship : Marginalized by society and yet ready to challenge its norms
Prices and Clinical Benefit of National Price-Negotiated Anticancer Medicines in China
We are not ready yet: limitations of state-of-the-art disease named entity recognizers
Yet
The management of multi-morbidity in elderly patients: Ready yet for precision medicine in intensive care?
Diabetes precision medicine: plenty of potential, pitfalls and perils but not yet ready for prime time
Quantifying benefit-risk preferences for new medicines in rare disease patients and caregivers